Explore
Validate
Learn19848-1-AP
antibody from Proteintech Group
Targeting: RTRAF
C14orf166, CGI-99, CLE, CLE7, hCLE1, LCRP369, RLLM1
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunoprecipitation [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 19848-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#19848-1-AP, RRID:AB_10646485
- Product name
- C14orf166 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated C14orf166 antibody (Cat. #19848-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references A novel all-in-one conditional knockout system uncovered an essential role of DDX1 in ribosomal RNA processing.
Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer.
Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma.
C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer.
Suzuki T, Katada E, Mizuoka Y, Takagi S, Kazuki Y, Oshimura M, Shindo M, Hara T
Nucleic acids research 2021 Apr 19;49(7):e40
Nucleic acids research 2021 Apr 19;49(7):e40
Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer.
Zhou YW, Li R, Duan CJ, Gao Y, Cheng YD, Zhang CF
Bioscience reports 2018 Oct 31;38(5)
Bioscience reports 2018 Oct 31;38(5)
Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma.
Zhou YW, Li R, Duan CJ, Gao Y, Cheng YD, He ZW, Zeng JX, Zhang CF
Molecular medicine reports 2017 Feb;15(2):605-612
Molecular medicine reports 2017 Feb;15(2):605-612
C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
Zhang W, Ou J, Lei F, Hou T, Wu S, Niu C, Xu L, Zhang Y
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 Jan;37(1):369-79
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 Jan;37(1):369-79
C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer.
Cheang TY, Zhou HY, Chen W, Zhang B, Liu L, Yang J, Wang S, Li H
Journal of translational medicine 2016 Feb 17;14:54
Journal of translational medicine 2016 Feb 17;14:54
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse thymus tissue were subjected to SDS PAGE followed by western blot with 19848-1-AP(CLE; C14orf166 antibody) at dilution of 1:1000
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of HepG2 cells, using C14orf166 antibody 19848-1-AP at 1:50 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- IP Result of anti-CLE; C14orf166 (IP:19848-1-AP, 3ug; Detection:19848-1-AP 1:700) with Jurkat cells lysate 1080ug.
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human heart using 19848-1-AP(CLE; C14orf166 antibody) at dilution of 1:100 (under 40x lens)
- Sample type
- tissue
